Yahoo
Swiss - Delayed Quote CHF

Straumann Holding AG (STMN.SW)

93.94 -1.08 (-1.14%)
At close: September 4 at 5:31:48 PM GMT+2
Chart Range Bar
Loading chart for STMN.SW
  • Previous Close 95.02
  • Open 95.02
  • Bid 93.94 x --
  • Ask 97.46 x --
  • Day's Range 93.94 - 95.56
  • 52 Week Range 73.02 - 109.80
  • Volume 330,447
  • Avg. Volume 350,839
  • Market Cap (intraday) 14.979B
  • Beta (5Y Monthly) 1.37
  • PE Ratio (TTM) 40.67
  • EPS (TTM) 2.31
  • Earnings Date Oct 28, 2026
  • Forward Dividend & Yield 1.00 (1.06%)
  • Ex-Dividend Date Apr 21, 2026
  • 1y Target Est 111.44

Straumann Holding AG provides tooth replacement and orthodontic solutions in Switzerland, the United States, China, Germany, Brazil, Japan, France, and internationally. It operates through Sales Europe, Middle East and Africa; Sales North America; Sales Asia Pacific; Sales Latin America; and Operations segments. The company offers dental implants, instruments, CADCAM prosthetics, orthodontic and clear aligners, biomaterials, and digital equipment and solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. It also provides implant systems, components, and related instruments, as well as healing components, materials and surfaces, surgical sets and instruments, and guided surgery and navigation products; prosthetics, including angled solutions, connections, components, and molar solutions; intra-oral and lab scanners, milling machines, dynamic navigation systems, and 3D printers; consumables, such as blocks, discs, resins, titanium bases, and abutment blanks, as well as scan bodies, analogs, and sleeves; online education; and dentists and dental labs solutions. In addition, the company offers regenerative solutions for tooth preservation, implant-site management, and implant preservation; scanner hardware, software licenses, sterile-packaged products, customer training, and other products; and logistics and supply chain services. Further, it provides thermoplastics; implant treatment referral; high-tech materials; artificial intelligence solutions for dental applications; and 3D orthodontic treatment animations. The company sells its products under the Straumann, Neodent, Medentika, Anthogyr, ClearCorrect, NUVO, and other brands through a network of distribution subsidiaries and partners, and third-party distributors, as well as through its e-shop. It serves clinicals needs, patient segments, and healthcare systems. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.

www.straumann.com

11,582

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 9/4/2026, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

STMN.SW
1.63%
MSCI WORLD (^990100-USD-STRD)
11.86%

1-Year Return

STMN.SW
2.20%
MSCI WORLD (^990100-USD-STRD)
19.91%

3-Year Return

STMN.SW
27.88%
MSCI WORLD (^990100-USD-STRD)
0.00%

5-Year Return

STMN.SW
45.21%
MSCI WORLD (^990100-USD-STRD)
57.61%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 706.47M
Earnings --
Profit Margin 0.00%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
200M
400M
600M
0.0%

Analyst Insights

View More

Analyst Price Targets

86.00 Low
111.44 Average
93.94 Current
136.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (5yr expected)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    14.00%

  • Return on Assets (ttm)

    10.99%

  • Return on Equity (ttm)

    17.05%

  • Revenue (ttm)

    2.64B

  • Net Income Avi to Common (ttm)

    369.18M

  • Diluted EPS (ttm)

    2.31

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    414.6M

  • Total Debt/Equity (mrq)

    20.76%

  • Levered Free Cash Flow (ttm)

    399.02M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: